Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Helene Schlageter

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Hematology|April 5, 2012
Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patientEirini Kouroupi, Bruno Cassinat, Marie-Helene Schlageter, et al.
BMC Cancer|March 28, 2012
Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapyPierre Blanchard, Laurent Quero, Vincent Pacault, et al.
International Journal of Laboratory Hematology|July 3, 2020
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patientsEmmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, et al.
British Journal of Haematology|June 12, 2008
Auer rods and differentiation in acute promyelocytic leukemiaFabien Zassadowski, Lionel Ades, Marie-Helene Schlageter, et al.
Annals of Hematology|September 28, 2018
Next-generation sequencing for JAK2 mutation testing: advantages and pitfallsNabih Maslah, Emmanuelle Verger, Marie-Helene Schlageter, et al.
European Thyroid Journal|July 20, 2018
Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European ExperienceMarie Alix Balay, Patrick Aidan, Marie Helene Schlageter, et al.
Haematologica|June 27, 2020
Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurementsLouis Drevon, Nabih Maslah, Juliette Soret-Dulphy, et al.
Blood|May 27, 2006
Frequent antibody production against RARalpha in both APL mice and patientsMarie Robin, Juliette Andreu-Gallien, Marie-Helene Schlageter, et al.
Haematologica|September 7, 2019
Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemiaNabih Maslah, Norman Salomao, Louis Drevon, et al.
Oncotarget|September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesCarole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Hematology|April 5, 2012
Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patientEirini Kouroupi, Bruno Cassinat, Marie-Helene Schlageter, et al.
BMC Cancer|March 28, 2012
Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapyPierre Blanchard, Laurent Quero, Vincent Pacault, et al.
International Journal of Laboratory Hematology|July 3, 2020
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patientsEmmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, et al.
British Journal of Haematology|June 12, 2008
Auer rods and differentiation in acute promyelocytic leukemiaFabien Zassadowski, Lionel Ades, Marie-Helene Schlageter, et al.
Annals of Hematology|September 28, 2018
Next-generation sequencing for JAK2 mutation testing: advantages and pitfallsNabih Maslah, Emmanuelle Verger, Marie-Helene Schlageter, et al.
European Thyroid Journal|July 20, 2018
Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European ExperienceMarie Alix Balay, Patrick Aidan, Marie Helene Schlageter, et al.
Haematologica|June 27, 2020
Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurementsLouis Drevon, Nabih Maslah, Juliette Soret-Dulphy, et al.
Blood|May 27, 2006
Frequent antibody production against RARalpha in both APL mice and patientsMarie Robin, Juliette Andreu-Gallien, Marie-Helene Schlageter, et al.
Haematologica|September 7, 2019
Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemiaNabih Maslah, Norman Salomao, Louis Drevon, et al.
Oncotarget|September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesCarole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Pageof 2